Radiation therapy for brain metastases in breast cancer patients

Breast Cancer

Volumn 18, Issue 4, 2011, Pages 244-251

  Aoyama, Hidefumi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Brain metastases; Breast cancer; Radiation therapy; Stereotactic radiosurgery; Whole brain radiation therapy

Indexed keywords

BEVACIZUMAB; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TRASTUZUMAB;

ARTICLE; BONE METASTASIS; BRAIN METASTASIS; BREAST CANCER; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; DISTANT METASTASIS; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG NON SMALL CELL CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; STEREOTACTIC RADIOSURGERY; SURVIVAL TIME; TUMOR RECURRENCE; WHOLE BRAIN RADIOTHERAPY;

BRAIN NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; PROGNOSIS; RADIOSURGERY; RISK FACTORS;

EID: 79961028763     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/s12282-010-0207-8     Document Type: Article

References (47)

1. Y Tsukada A Fouad JW Pickren WW Lane 1983 Central nervous system metastasis from breast carcinoma Autopsy Study Cancer 52 12 2349 2354 1:STN:280:DyaL2c%2FlsV2qtg%3D%3D (Pubitemid 14205961)
2. ES Nussbaum HR Djalilian KH Cho WA Hall 1996 Brain metastases. Histology, multiplicity, surgery, and survival Cancer 78 8 1781 1788 8859192 10.1002/(SICI)1097-0142(19961015)78:8<1781::AID-CNCR19>3.0.CO;2-U 1:STN:280:DyaK2s%2Fht1ektQ%3D%3D (Pubitemid 26330907)
3. JL Frazier S Batra S Kapor A Vellimana R Gandhi KA Carson, et al. 2010 Stereotactic radiosurgery in the management of brain metastases: an institutional retrospective analysis of survival Int J Radiat Oncol Biol Phys 76 5 1486 1492 19619958 10.1016/j.ijrobp.2009.03.028
4. DW Golden KR Lamborn MW McDermott S Kunwar WM Wara JL Nakamura, et al. 2008 Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site J Neurosurg 109 77 86 19123892 10.3171/JNS/2008/109/7/0077 (Pubitemid 351930524)
5. J Lorenzoni D Devriendt N Massager P David S Ruiz B Vanderlinden, et al. 2004 Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems Int J Radiat Oncol Biol Phys 60 1 218 224 15337559 10.1016/j.ijrobp.2004.02.017 (Pubitemid 39165488)
6. RA Patchell PA Tibbs JW Walsh RJ Dempsey Y Maruyama RJ Kryscio, et al. 1990 A randomized trial of surgery in the treatment of single metastases to the brain N Engl J Med 322 8 494 500 2405271 10.1056/NEJM199002223220802 1:STN:280:DyaK3c7js1OlsQ%3D%3D (Pubitemid 20067825)
7. CJ Vecht H Haaxma-Reiche EM Noordijk GW Padberg JH Voormolen FH Hoekstra, et al. 1993 Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 33 6 583 590 8498838 10.1002/ana. 410330605 1:STN:280:DyaK3s3ntVClsQ%3D%3D (Pubitemid 23161878)
8. AH Mintz J Kestle MP Rathbone L Gaspar H Hugenholtz B Fisher, et al. 1996 A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis Cancer 78 7 1470 1476 8839553 10.1002/(SICI)1097-0142(19961001)78:7<1470::AID-CNCR14>3.0.CO;2-X 1:STN:280:DyaK28vjs1OgtQ%3D%3D (Pubitemid 26317868)
9. RA Patchell PA Tibbs WF Regine RJ Dempsey M Mohiuddin RJ Kryscio, et al. 1998 Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial JAMA 280 17 1485 1489 9809728 10.1001/jama.280.17.1485 1:STN:280:DyaK1M%2FisFKjsg%3D%3D (Pubitemid 28507400)
10. H Aoyama H Shirato M Tago K Nakagawa T Toyoda K Hatano, et al. 2006 Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial JAMA 295 21 2483 2491 16757720 10.1001/jama.295.21.2483 1:CAS:528:DC%2BD28XlsV2ltbo%3D (Pubitemid 43854963)
11. DW Andrews CB Scott PW Sperduto AE Flanders LE Gaspar MC Schell, et al. 2004 Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial Lancet 363 9422 1665 1672 15158627 10.1016/S0140-6736(04)16250-8 (Pubitemid 38670323)
12. W Boogerd VW Vos AA Hart G Baris 1993 Brain metastases in breast cancer; natural history, prognostic factors and outcome J Neurooncol 15 2 165 174 8509821 10.1007/BF01053937 1:STN:280:DyaK3s3os1KmtQ%3D%3D (Pubitemid 23136031)
13. A DiStefano Y Yong Yap GN Hortobagyi GR Blumenschein 1979 The natural history of breast cancer patients with brain metastases Cancer 44 5 1913 1918 498057 10.1002/1097-0142(197911)44:5<1913::AID-CNCR2820440554>3.0.CO;2-D 1:STN:280:DyaL3c%2FksVKhsw%3D%3D (Pubitemid 10141974)
14. MP Mehta P Rodrigus CH Terhaard A Rao J Suh W Roa, et al. 2003 Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases J Clin Oncol 21 13 2529 2536 12829672 10.1200/JCO.2003.12.122 1:CAS:528:DC%2BD2cXptlCkt78%3D (Pubitemid 46606335)
15. LJ Schouten J Rutten HA Huveneers A Twijnstra 2002 Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma Cancer 94 10 2698 2705 12173339 10.1002/cncr.10541 (Pubitemid 34478086)
16. LE Gaspar K Chansky KS Albain E Vallieres V Rusch JJ Crowley, et al. 2005 Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group J Clin Oncol 23 13 2955 2961 15860851 10.1200/JCO.2005.08.026 (Pubitemid 46224114)
17. M Ono M Ando M Yunokawa E Nakano K Yonemori K Matsumoto, et al. 2009 Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer Int J Clin Oncol 14 1 48 52 19225924 10.1007/s10147-008-0797-8 1:CAS:528:DC%2BD1MXitVygtL4%3D
18. DD Maki RI Grossman 2000 Patterns of disease spread in metastatic breast carcinoma: influence of estrogen and progesterone receptor status AJNR Am J Neuroradiol 21 6 1064 1066 10871014 1:STN:280:DC%2BD3cvosVyqtw%3D%3D (Pubitemid 30390543)
19. Z Gabos R Sinha J Hanson N Chauhan J Hugh JR Mackey, et al. 2006 Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer J Clin Oncol 24 36 5658 5663 17102066 10.1200/JCO.2006.07.0250 1:CAS:528: DC%2BD2sXhtVChsrc%3D (Pubitemid 46631306)
20. IL Atahan G Ozyigit F Yildiz M Gurkaynak U Selek S Sari, et al. 2008 Percent positive axillary involvement predicts for the development of brain metastasis in high-risk patients with nonmetastatic breast cancer receiving post-mastectomy radiotherapy Breast J 14 3 245 249 18433402 10.1111/j.1524-4741. 2008.00569.x (Pubitemid 351678055)
21. P Saip I Cicin Y Eralp H Karagol S Kucucuk R Cosar Alas, et al. 2009 Identification of patients who may benefit from the prophylactic cranial radiotherapy among breast cancer patients with brain metastasis J Neurooncol 93 2 243 251 19099196 10.1007/s11060-008-9769-0
22. R Duchnowska R Dziadziuszko B Czartoryska-Arlukowicz B Radecka B Szostakiewicz K Sosinska-Mielcarek, et al. 2009 Risk factors for brain relapse in HER2-positive metastatic breast cancer patients Breast Cancer Res Treat 117 2 297 303 19130219 10.1007/s10549-008-0275-z 1:CAS:528:DC%2BD1MXpvF2gt78%3D
23. SS Lee JH Ahn MK Kim SJ Sym G Gong SD Ahn, et al. 2008 Brain metastases in breast cancer prognostic factors and management Breast Cancer Res Treat 111 3 523 530 17990100 10.1007/s10549-007-9806-2
24. B Leyland-Jones 2009 Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases J Clin Oncol 27 31 5278 5286 19770385 10.1200/JCO.2008.19.8481
25. KD Miller T Weathers LG Haney R Timmerman M Dickler J Shen, et al. 2003 Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival Ann Oncol 14 7 1072 1077 12853349 10.1093/annonc/mdg300 1:STN:280:DC%2BD3szitlCrtg%3D%3D (Pubitemid 36950171)
26. K Matsumoto M Ando C Yamauchi C Egawa Y Hamamoto M Kataoka, et al. 2009 Questionnaire survey of treatment choice for breast cancer patients with brain metastasis in Japan: results of a nationwide survey by the task force of the Japanese Breast Cancer Society Jpn J Clin Oncol 39 1 22 26 19008214 10.1093/jjco/hyn124
27. R Lai CT Dang MG Malkin LE Abrey 2004 The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma Cancer 101 4 810 816 15305414 10.1002/cncr.20418 1:CAS:528:DC%2BD2cXntlSqtbo%3D (Pubitemid 39030939)
28. V Wolstenholme M Hawkins S Ashley D Tait G Ross 2008 HER2 significance and treatment outcomes after radiotherapy for brain metastases in breast cancer patients Breast 17 6 661 665 18571923 10.1016/j.breast.2008.04.006
29. GA Viani SL Afonso EJ Stefano LI De Fendi FV Soares 2007 Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials BMC Cancer 7 153 17686164 10.1186/1471-2407-7-153 (Pubitemid 47354734)
30. EE Lower DR Drosick R Blau L Brennan W Danneman DK Hawley 2003 Increased rate of brain metastasis with trastuzumab therapy not associated with impaired survival Clin Breast Cancer 4 2 114 119 12864939 10.3816/CBC.2003.n.016 1:CAS:528:DC%2BD3sXmt1Olsrk%3D (Pubitemid 36939417)
31. Niwinska A, Murawska M, Pogoda K. Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT). Ann Oncol. Oct 19 2009.
32. MT Liu CY Hsieh AY Wang TH Chang CP Pi CC Huang, et al. 2006 Prognostic factors affecting the outcome of brain metastases from breast cancer Support Care Cancer 14 9 936 942 16575571 10.1007/s00520-006-0029-6
33. GA Viani MS Castilho JV Salvajoli AC Pellizzon PE Novaes FS Guimaraes, et al. 2007 Whole brain radiotherapy for brain metastases from breast cancer estimation of survival using two stratification systems BMC Cancer 7 53 17386108 10.1186/1471-2407-7-53 (Pubitemid 46566604)
34. S Goyal D Prasad F Harrell Jr J Matsumoto T Rich L Steiner 2005 Gamma knife surgery for the treatment of intracranial metastases from breast cancer J Neurosurg 103 2 218 223 16175849 10.3171/jns.2005.103.2.0218 (Pubitemid 43193895)
35. MA Socinski CJ Langer JE Huang J Matsumoto T Rich L Steiner 2009 Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases J Clin Oncol 27 31 5255 5261 19738122 10.1200/JCO.2009.22.0616 1:CAS:528:DC%2BD1MXhsFahsLjL
36. T Seute P Leffers GP ten Velde A Twijnstra 2008 Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI) Cancer 112 8 1827 1834 18311784 10.1002/cncr.23361 (Pubitemid 351536844)
37. L Gaspar C Scott M Rotman S Asbell T Phillips T Wasserman, et al. 1997 Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials Int J Radiat Oncol Biol Phys 37 4 745 751 9128946 10.1016/S0360-3016(96)00619-0 1:STN:280: DyaK2s3nsFSmsA%3D%3D (Pubitemid 27181303)
38. O Agboola B Benoit P Cross V Da Silva B Esche H Lesiuk, et al. 1998 Prognostic factors derived from recursive partition analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases Int J Radiat Oncol Biol Phys 42 1 155 159 9747833 1:STN:280:DyaK1cvhvVKjtw%3D%3D (Pubitemid 28435608)
39. MA Chidel JH Suh CA Reddy ST Chao MF Lundbeck GH Barnett 2000 Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases Int J Radiat Oncol Biol Phys 47 4 993 999 10863070 10.1016/S0360-3016(00)00527-7 1:STN:280:DC%2BD3czitlaguw%3D%3D (Pubitemid 30345598)
40. SN Sanghavi SS Miranpuri R Chappell JM Buatti PK Sneed JH Suh, et al. 2001 Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method Int J Radiat Oncol Biol Phys 51 2 426 434 11567817 10.1016/S0360-3016(01)01622-4 1:STN:280:DC%2BD3Mrit1SrsQ%3D%3D (Pubitemid 32884288)
41. TC Samuel HB Gene WL Stephanie MR Alwyn AT Steven AV Michael, et al. 2006 Five-year survivors of brain metastases: a single-institution report of 32 patients Int J Radiat Oncol Biol Phys 66 3 801 809 10.1016/j.ijrobp.2006.05.015 (Pubitemid 44436686)
42. MMV Gregory AR Chandana TC Samuel WR Thomas JA David HB Gene, et al. 2009 Gender, race, and survival: a study in non-small-cell lung cancer brain metastases patients utilizing the Radiation Therapy Oncology Group recursive partitioning analysis classification Int J Radiat Oncol Biol Phys 75 4 1141 1147 10.1016/j.ijrobp.2008.12.022
43. S Akyurek EL Chang A Mahajan SJ Hassenbusch PK Allen LA Mathews, et al. 2007 Stereotactic radiosurgical treatment of cerebral metastases arising from breast cancer Am J Clin Oncol 30 3 310 314 17551311 10.1097/01.coc.0000258365. 50975.f6 (Pubitemid 46884154)
44. D Rades R Lohynska T Veninga LJ Stalpers SE Schild 2007 Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients Cancer 110 11 2587 2592 17893909 10.1002/cncr.23082 (Pubitemid 350174946)
45. R Le Scodan C Massard E Mouret-Fourme JM Guinebretierre C Cohen-Solal B De Lalande, et al. 2007 Brain metastases from breast carcinoma: validation of the Radiation Therapy Oncology Group recursive partitioning analysis classification and proposition of a new prognostic score Int J Radiat Oncol Biol Phys 69 3 839 845 17544592 10.1016/j.ijrobp.2007.04.024 (Pubitemid 47418410)
46. H Harputluoglu O Dizdar S Aksoy S Kilickap DS Dede Y Ozisik, et al. 2008 Characteristics of breast cancer patients with central nervous system metastases: a single-center experience J Natl Med Assoc 100 5 521 526 18507204 (Pubitemid 351717364)
47. W Boogerd AA Hart IS Tjahja 1997 Treatment and outcome of brain metastasis as first site of distant metastasis from breast cancer J Neurooncol 35 2 161 167 9266454 10.1023/A:1005818323996 1:STN:280:DyaK2svhtFCktA%3D%3D (Pubitemid 27361686)